Synthesis and Properties of 3-Fluorocyclobutylamines
[10] a) G. Haufe, S. Kröger, Amino Acids 1996, 11, 409–424; b) T. C.
Rosen, S. Yoshida, R. Fröhlich, K. L. Kirk, G. Haufe, J. Med.
Chem. 2004, 47, 5860–5871; c) T. C. Rosen, S. Yoshida, K. L.
Kirk, G. Haufe, ChemBioChem 2004, 5, 1033–1043; d) M.
Morgenthaler, E. Schweizer, A. Hoffmann-Röder, F. Benini,
R. E. Martin, G. Jaeschke, B. Wagner, H. Fischer, S. Bendels,
D. Zimmerli, J. Schneider, F. Diederich, M. Kansy, K. Müller,
ChemMedChem 2007, 2, 1100–1115; e) Q. A. Huchet, B. Kuhn,
B. Wagner, H. Fischer, M. Kansy, D. Zimmerli, E. M. Carreira,
K. Müller, J. Fluorine Chem. 2013, 152, 119–128; f) B. E.
Smart, J. Fluorine Chem. 2001, 109, 3–11.
[11] a) Y. Zhao, L. Liu, W. Sun, J. Lu, D. McEachern, X. Li, S. Yu,
D. Bernard, P. Ochsenbein, V. Ferey, J.-C. Carry, J. R. De-
schamps, D. Sun, S. Wang, J. Am. Chem. Soc. 2013, 135, 7223–
7234; b) X. Du, R. J. Hinklin, Y. Xiong, P. Dransfield, J. Park,
T. J. Kohn, V. Pattaropong, S. J. Lai, Z. Fu, X. Jiao, D. Chow,
L. Jin, J. Davda, M. M. Veniant, D. A. Anderson, B. R. Baer,
J. R. Bencsik, S. A. Boyd, M. J. Chicarelli, P. J. Mohr, B. Wang,
K. R. Condroski, W. E. DeWolf, M. Conn, T. Tran, J. Yang,
T. D. Aicher, J. C. Medina, P. Coward, J. B. Houze, ACS Med.
Chem. Lett. 2014, 5, 1284–1289.
[12] Prefixes cis and trans are related to the orientation of the
methyl/aryl substituent with regard to the carboxy hydroxy or
amino groups. In this way, diastereomeric fluorinated com-
pounds, for example cis-13 and trans-13, have the same stereo-
chemical descriptor of the substituent arrangement as the non-
fluorinated parent compounds cis-17 and trans-17.
[13] a) C. Beard, A. Burger, J. Org. Chem. 1962, 27, 1647–1650;
b) J.-B. Falmagne, J. Escudero, S. Taleb-Sahraoui, L. Ghosez,
Angew. Chem. Int. Ed. 1981, 20, 879–880; Angew. Chem. 1981,
93, 926–931.
[14] For the application of a similar synthetic approach in cis-1,3-
substituted cyclobutanes, see: D. S. Radchenko, S. O. Pavlenko,
O. O. Grygorenko, D. M. Volochnyuk, S. V. Shishkina, O. V.
Shishkin, I. V. Komarov, J. Org. Chem. 2010, 75, 5941–5952.
[15] a) D. O’Hagan, Chem. Soc. Rev. 2008, 37, 308–319; b) L.
Hunter, Beilstein J. Org. Chem. 2010, 6, DOI: 10.3762/
bjoc.6.38; c) X.-G. Hu, L. Hunter, Beilstein J. Org. Chem. 2013,
9, 2696–2708.
spectra and B. Hildmann (Organisch-Chemisches Institut, Uni-
versität Münster) for measuring the pKa values. Support by Pro-
fessor Dr. U. Karst (Institut für Anorganische und Analytische
Chemie, Universität Münster) is gratefully acknowledged.
[1]
[2]
C. M. Marson, Chem. Soc. Rev. 2011, 40, 5514–5533.
F. W. Goldberg, J. G. Kettle, T. Kogej, M. W. D. Perry, N. P.
Tomkinson, Drug Discovery Today 2015, 20, 11–17.
[3]
For recent examples, see: a) A. Avenoza, J. H. Busto, N. Canal,
F. Corzana, J. M. Peregrina, M. Perez-Fernandez, F. Rodrıg-
uez, J. Org. Chem. 2010, 75, 545–552; b) A. N. Tkachenko,
D. S. Radchenko, P. K. Mykhailiuk, S. Afonin, A. S. Ulrich,
I. V. Komarov, Angew. Chem. Int. Ed. 2013, 52, 6504–6507; An-
gew. Chem. 2013, 125, 6632; c) D. S. Radchenko, O. M. Michu-
rin, O. O. Grygorenko, K. Scheinpflug, M. Dathe, I. V. Koma-
rov, Tetrahedron 2013, 69, 505–511; d) A. V. Chernykh, D. S.
Radchenko, O. O. Grygorenko, D. M. Volochnyuk, S. V. Shish-
kina, O. V. Shishkin, I. V. Komarov, RSC Adv. 2014, 4, 10894–
10902.
[4]
T. T. Wager, B. A. Pettersen, A. W. Schmidt, D. K. Spracklin,
S. Mente, T. W. Butler, H. Howard Jr., D. J. Lettiere, D. M. Ru-
bitski, D. F. Wong, F. M. Nedza, F. R. Nelson, H. Rollema,
J. W. Raggon, J. Aubrecht, J. K. Freeman, J. M. Marcek, J. Ci-
anfrogna, K. W. Cook, L. C. James, L. A. Chatman, P. A. Ired-
ale, M. J. Banker, M. L. Homiski, J. B. Munzner, R. Y. Chand-
rasekaran, J. Med. Chem. 2011, 54, 7602–7620.
[5] E. J. Olhava, R. Chesworth, K. W. Kuntz, V. M. Richon, R. M.
Pollock, S. R. Daigle, PCT Int. Patent Appl. US 2013/058537,
2013.
[6] A. L. Castelhano, G. A. Cutting, A. J. Locke, Y. Mao, K. M.
Mulvihill, R. Norrie, A. J. O’Brien, S. R. Park, J. A. Rechka,
A. M. Stevens, C. I. Thomas, PCT Int. Patent Appl. US 2011/
045807, 2011.
[7] Y. Zhu, S. H. Olson, D. Graham, G. Patel, A. Hermanowski-
Vosatka, S. Mundt, K. Shah, M. Springer, R. Thieringer, S.
Wright, J. Xiao, H. Zokian, J. Dragovic, J. M. Balkovec, Bioorg.
Med. Chem. Lett. 2010, 20, 2452–2455.
[8] a) J. Wang, M. Sánchez-Roselló, J. L. Aceña, C. del Pozo, A. E.
Sorochinsky, S. Fustero, V. A. Soloshonok, H. Liu, Chem. Rev.
2014, 114, 2432–2506; b) K. Müller, C. Faeh, F. Diederich, Sci-
ence 2007, 317, 1881–1886; c) W. K. Hagmann, J. Med. Chem.
2008, 51, 4359–4369; d) S. Purser, P. R. Moore, S. Swallow, V.
Gouverneur, Chem. Soc. Rev. 2008, 37, 320–330; e) J.-P. Bégué,
D. Bonnet-Delpon, Bioorganic and Medicinal Chemistry of
Fluorine, John Wiley & Sons, Hoboken, USA, 2008, p. 365; f)
Fluorine and Health, Molecular Imaging, Biomedical Materials
and Pharmaceuticals (Eds.: A. Tressaud, G. Haufe), Elsevier,
Amsterdam, 2008, p. 553–778; g) Fluorine in Medicinal Chemis-
try and Chemical Biology (Ed.: I. Ojima), Wiley-Blackwell,
2009, p. 3–198; h) Fluorine in Pharmaceutical and Medicinal
Chemistry, From Biophysical Aspects to Clinical Application
(Eds.: V. Gouverneur, K. Müller), Imperial College Press, Lon-
don, 2012, p. 139–331.
[16] a) I. Hyla-Kryspin, S. Grimme, S. Hruschka, G. Haufe, Org.
Biomol. Chem. 2008, 6, 4167–4175; b) H.-J. Schneider, Chem.
Sci. 2012, 3, 1381–1394; c) P. A. Champagne, J. Desroches, J.-
F. Paquin, Synthesis 2015, 47, 306–322.
[17] CCDC-1046701 (for cis-12b) and 1046702 (for trans-12b) con-
tain the supplementary crystallographic data for this paper.
These data can be obtained free of charge from The Cambridge
Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_
request/cif.
[18] W. R. Dolbier Jr., Guide to Fluorine NMR for Organic Chem-
ists, John Wiley & Sons, Hoboken, 2009, p. 45.
[19] The Handbook of Medicinal Chemistry. Principles and Practice
(Eds.: A. Davis, S. E. Ward), Royal Society of Chemistry, Cam-
bridge, UK, 2014, p. 4–5.
[20] S. Hruschka, T. C. Rosen, S. Yoshida, K. L. Kirk, R. Fröhlich,
B. Wibbeling, G. Haufe, Bioorg. Med. Chem. 2008, 16, 7148–
7166.
[9] For representative examples, see: a) P. P. Shao, F. Ye, Tetrahe-
dron Lett. 2008, 49, 3554–3557; b) M. Moens, M. D’Hooghe,
N. De Kimpe, Tetrahedron Lett. 2013, 54, 6110–6113; c) G. R.
Krow, R. Edupuganti, D. Gandla, F. Yu, M. Sender, P. E. Son-
net, M. J. Zdilla, C. DeBrosse, K. C. Cannon, C. W. Ross III,
A. Choudhary, M. D. Shoulders, R. T. Raine, J. Org. Chem.
2011, 76, 3626–3634; d) W. Yu, L. Williams, V. M. Camp, J. J.
Olson, M. M. Goodman, Bioorg. Med. Chem. Lett. 2010, 20,
2140–2143.
[21] a) R. B. Silverman, J. Biol. Chem. 1983, 258, 14766–14769; b)
R. B. Silverman, Acc. Chem. Res. 1995, 28, 335–342.
[22] Z. Otwinowski, W. Minor, Methods Enzymol. 1997, 276, 307–
326.
[23] Z. Otwinowski, D. Borek, W. Majewski, W. Minor, Acta Crys-
tallogr., Sect. A 2003, 59, 228–234.
[24] G. M. Sheldrick, Acta Crystallogr., Sect. A 1990, 46, 467–473.
[25] G. M. Sheldrick, Acta Crystallogr., Sect. A 2008, 64, 112–122.
Received: June 6, 2015
Published Online: August 25, 2015
Eur. J. Org. Chem. 2015, 6466–6471
© 2015 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
6471